Bis-ketol nucleoside triesters as prodrugs of the antiviral nucleoside triphosphate analogues of 3'-deoxythymidine and 3'-deoxy-2',3'-didehydrothymidine.

about

Bis-ketol nucleoside triesters as prodrugs of the antiviral nucleoside triphosphate analogues of 3'-deoxythymidine and 3'-deoxy-2',3'-didehydrothymidine.

Item

http://www.wikidata.org/entity/Q40562095

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Bis-ketol nucleoside triesters ...... eoxy-2',3'-didehydrothymidine.

@en

type

Item

label

Bis-ketol nucleoside triesters ...... eoxy-2',3'-didehydrothymidine.

@en

prefLabel

Bis-ketol nucleoside triesters ...... eoxy-2',3'-didehydrothymidine.

@en

P1476

Bis-ketol nucleoside triesters ...... eoxy-2',3'-didehydrothymidine.

@en

P2093

Gerald F Koser

http://www.w3.org/2001/XMLSchema#string

Kim C Calvo

http://www.w3.org/2001/XMLSchema#string

Xiaohong Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Aryl phosphate derivatives of AZT retain activity against HIV1 in cell lines which are resistant to the action of AZT

Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro.

Synthesis and antitumor evaluation of bis[(pivaloyloxy)methyl] 2'-deoxy-5-fluorouridine 5'-monophosphate (FdUMP): a strategy to introduce nucleotides into cells.

Novel nucleoside strategies for anti-HIV and anti-HSV therapy.

The potential of nucleotide analogs as inhibitors of retroviruses and tumors.

Minireview: nucleotide prodrugs.

Synthesis and biological evaluation of some phosphate triester derivatives of the anti-viral drug AraA.

Nucleoside analogues previously found to be inactive against HIV may be activated by simple chemical phosphorylation.

Intracellular delivery of bioactive AZT nucleotides by aryl phosphate derivatives of AZT.

Comparative activity of 2',3'-saturated and unsaturated pyrimidine and purine nucleosides against human immunodeficiency virus type 1 in peripheral blood mononuclear cells.

P304

637-646

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1081/NCN-120030723

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15113029

http://www.w3.org/2001/XMLSchema#string